Gå direkte til indholdet

Kardiotorakal- og karkirurgi (pædiatri)

Optimere hæmostase

Antifibrinolytika

Avoiding transfusions in children undergoing cardiac surgery: a meta-analysis of randomized trials of aprotinin. (åbner nyt vindue)

Arnold DM, Fergusson DA, Chan AK, Cook RJ, Fraser GA, Lim W, Blajchman MA, Cook DJ.

Kilde‎: Anesth Analg 2006;102(3):731-7.

Indekseret‎: PubMed 16492820

DOI‎: 10.1213/01.ane.0000194954.64293.61

https://www.ncbi.nlm.nih.gov/pubmed/16492820 (åbner nyt vindue)

A systematic review of the use of antifibrinolytic agents in pediatric surgery and implications for craniofacial use. (åbner nyt vindue)

Basta MN, Stricker PA, Taylor JA.

Kilde‎: Pediatr Surg Int 2012;28(11):1059-69.

Indekseret‎: PubMed 22940882

DOI‎: 10.1007/s00383-012-3167-6

https://www.ncbi.nlm.nih.gov/pubmed/22940882 (åbner nyt vindue)

Aprotinin, transfusions, and kidney injury in neonates and infants undergoing cardiac surgery. (åbner nyt vindue)

Bojan M, Vicca S, Boulat C, Gioanni S, Pouard P.

Kilde‎: Br J Anaesth 2012;108(5):830-7.

Indekseret‎: PubMed 22362670

DOI‎: 10.1093/bja/aes002

https://www.ncbi.nlm.nih.gov/pubmed/22362670 (åbner nyt vindue)

Comparison of epsilon aminocaproic acid and tranexamic acid in pediatric cardiac surgery. (åbner nyt vindue)

Chauhan S, Das SN, Bisoi A, Kale S, Kiran U.

Kilde‎: J Cardiothorac Vasc Anesth 2004;18(2):141-3.

Indekseret‎: PubMed 15073700

https://www.ncbi.nlm.nih.gov/pubmed/15073700 (åbner nyt vindue)

Efficacy of aprotinin, epsilon aminocaproic acid, or combination in cyanotic heart disease. (åbner nyt vindue)

Chauhan S, Kumar BA, Rao BH, Rao MS, Dubey B, Saxena N, Venugopal P.

Kilde‎: Ann Thorac Surg 2000;70(4):1308-12.

Indekseret‎: PubMed 11081890

https://www.ncbi.nlm.nih.gov/pubmed/11081890 (åbner nyt vindue)

The Bayer 022 compassionate-use pediatric study. (åbner nyt vindue)

Coniff RF.

Kilde‎: Ann Thorac Surg 1998;65(6 Suppl):S31-3.

Indekseret‎: PubMed 9647135

https://www.ncbi.nlm.nih.gov/pubmed/9647135 (åbner nyt vindue)

Differential effects of aprotinin and tranexamic acid on outcomes and cytokine profiles in neonates undergoing cardiac surgery. (åbner nyt vindue)

Graham EM, Atz AM, Gillis J, Desantis SM, Haney AL, Deardorff RL, Uber WE, Reeves ST, McGowan FX Jr, Bradley SM, Spinale FG.

Kilde‎: J Thorac Cardiovasc Surg 2012;143(5):1069-76.

Indekseret‎: PubMed 22075061

DOI‎: 10.1016/j.jtcvs.2011.08.051

https://www.ncbi.nlm.nih.gov/pubmed/22075061 (åbner nyt vindue)

Intraoperative tranexamic acid in pediatric bloodless cardiac surgery. (åbner nyt vindue)

Hasegawa T, Oshima Y, Maruo A, Matsuhisa H, Tanaka A, Noda R, Yokoyama S, Iwasaki K.

Kilde‎: Asian Cardiovasc Thorac Ann 2014;22(9):1039-45.

Indekseret‎: PubMed 24637029

DOI‎: 10.1177/0218492314527991

https://www.ncbi.nlm.nih.gov/pubmed/24637029 (åbner nyt vindue)

The safety and efficacy of antifibrinolytic therapy in neonatal cardiac surgery. (åbner nyt vindue)

Lin CY, Shuhaiber JH, Loyola H, Liu H, Del Nido P, DiNardo JA, Pigula FA.

Kilde‎: PLoS One 2015;10(5):e0126514.

Indekseret‎: PubMed 25954976

DOI‎: 10.1371/journal.pone.0126514

https://www.ncbi.nlm.nih.gov/pubmed/25954976 (åbner nyt vindue)

Tranexamic acid versus ɛ-aminocaproic acid: efficacy and safety in paediatric cardiac surgery. (åbner nyt vindue)

Martin K, Breuer T, Gertler R, Hapfelmeier A, Schreiber C, Lange R, Hess J, Wiesner G.

Kilde‎: Eur J Cardiothorac Surg 2011;39(6):892-7.

Indekseret‎: PubMed 21115357

DOI‎: 10.1016/j.ejcts.2010.09.041

https://www.ncbi.nlm.nih.gov/pubmed/21115357 (åbner nyt vindue)

Replacement of aprotinin by ε-aminocaproic acid in infants undergoing cardiac surgery: consequences for blood loss and outcome. (åbner nyt vindue)

Martin K, Gertler R, MacGuill M, Mayr NP, Hapfelmeier A, Hörer J, Vogt M, Tassani P, Wiesner G.

Kilde‎: Br J Anaesth 2013;110(4):615-21.

Indekseret‎: PubMed 23213034

DOI‎: 10.1093/bja/aes430

https://www.ncbi.nlm.nih.gov/pubmed/23213034 (åbner nyt vindue)

Hematologic and economic impact of aprotinin in reoperative pediatric cardiac operations. (åbner nyt vindue)

Miller BE, Tosone SR, Tam VK, Kanter KR, Guzzetta NA, Bailey JM, Levy JH.

Kilde‎: Ann Thorac Surg 1998;66(2):535-40; discussion 541.

Indekseret‎: PubMed 9725399

https://www.ncbi.nlm.nih.gov/pubmed/9725399 (åbner nyt vindue)

Efficacy of tranexamic acid as compared to aprotinin in open heart surgery in children. (åbner nyt vindue)

Muthialu N, Balakrishnan S, Sundar R, Muralidharan S.

Kilde‎: Ann Card Anaesth 2015;18(1):23-6.

Indekseret‎: PubMed 25566706

DOI‎: 10.4103/0971-9784.148316

https://www.ncbi.nlm.nih.gov/pubmed/25566706 (åbner nyt vindue)

Comparative analysis of antifibrinolytic medications in pediatric heart surgery. (åbner nyt vindue)

Pasquali SK, Li JS, He X, Jacobs ML, O'Brien SM, Hall M, Jaquiss RD, Welke KF, Peterson ED, Shah SS, Jacobs JP.

Kilde‎: J Thorac Cardiovasc Surg 2012;143(3):550-7.

Indekseret‎: PubMed 22264414

DOI‎: 10.1016/j.jtcvs.2011.06.048

https://www.ncbi.nlm.nih.gov/pubmed/22264414 (åbner nyt vindue)

Effective tranexamic acid concentration for 95% inhibition of tissue-type plasminogen activator induced hyperfibrinolysis in children with congenital heart disease: A prospective, controlled, in-vitro study. (åbner nyt vindue)

Rozen L, Faraoni D, Sanchez Torres C, Willems A, Noubouossie DC, Barglazan D, Van der Linden P, Demulder A.

Kilde‎: Eur J Anaesthesiol 2015;32(12):844-50.

Indekseret‎: PubMed 26258658

DOI‎: 10.1097/EJA.0000000000000316

https://www.ncbi.nlm.nih.gov/pubmed/26258658 (åbner nyt vindue)

Comparison of different doses of ε-aminocaproic acid in children for tetralogy of Fallot surgery: clinical efficacy and safety. (åbner nyt vindue)

Sarupria A, Makhija N, Lakshmy R, Kiran U.

Kilde‎: J Cardiothorac Vasc Anesth 2013;27(1):23-9.

Indekseret‎: PubMed 22995453

DOI‎: 10.1053/j.jvca.2012.07.001

https://www.ncbi.nlm.nih.gov/pubmed/22995453 (åbner nyt vindue)

Comparison of three dose regimens of aprotinin in infants undergoing the arterial switch operation. (åbner nyt vindue)

Verma YS, Chauhan S, Bisoi AK, Gharde P, Kiran U, Das SN.

Kilde‎: Ann Card Anaesth 2010;13(2):110-5.

Indekseret‎: PubMed 20442540

DOI‎: 10.4103/0971-9784.62935

https://www.ncbi.nlm.nih.gov/pubmed/20442540 (åbner nyt vindue)

Pharmacokinetics of tranexamic acid in neonates, infants, and children undergoing cardiac surgery with cardiopulmonary bypass. (åbner nyt vindue)

Wesley MC, Pereira LM, Scharp LA, Emani SM, McGowan FX Jr, DiNardo JA.

Kilde‎: Anesthesiology 2015;122(4):746-58.

Indekseret‎: PubMed 25585004

DOI‎: 10.1097/ALN.0000000000000570

https://www.ncbi.nlm.nih.gov/pubmed/25585004 (åbner nyt vindue)

Efficacy and safety of aprotinin in neonatal congenital heart operations. (åbner nyt vindue)

Wilder NS, Kavarana MN, Voepel-Lewis T, Paugh T, Lee T, Ohye RG.

Kilde‎: Ann Thorac Surg 2011;92(3):958-63.

Indekseret‎: PubMed 21871283

DOI‎: 10.1016/j.athoracsur.2011.04.094

https://www.ncbi.nlm.nih.gov/pubmed/21871283 (åbner nyt vindue)

The effect of preoperative tranexamic acid on blood loss after cardiac operations in children. (åbner nyt vindue)

Zonis Z, Seear M, Reichert C, Sett S, Allen C.

Kilde‎: J Thorac Cardiovasc Surg 1996;111(5):982-7.

Indekseret‎: PubMed 8622323

https://www.ncbi.nlm.nih.gov/pubmed/8622323 (åbner nyt vindue)

Rekombinant aktiveret Faktor VII (rFVIIa)

Recombinant factor seven therapy for postoperative bleeding in neonatal and pediatric cardiac surgery. (åbner nyt vindue)

Agarwal HS, Bennett JE, Churchwell KB, Christian KG, Drinkwater DC Jr, He Y, Taylor MB.

Kilde‎: Ann Thorac Surg 2007;84(1):161-8.

Indekseret‎: PubMed 17588404

DOI‎: 10.1016/j.athoracsur.2007.02.051

https://www.ncbi.nlm.nih.gov/pubmed/17588404 (åbner nyt vindue)

Pediatric off-label use of recombinant factor VIIa. (åbner nyt vindue)

Alten JA, Benner K, Green K, Toole B, Tofil NM, Winkler MK.

Kilde‎: Pediatrics 2009;123(3):1066-72.

Indekseret‎: PubMed 19255041

DOI‎: 10.1542/peds.2008-1685

https://www.ncbi.nlm.nih.gov/pubmed/19255041 (åbner nyt vindue)

Factor VII for excessive bleeding following congenital heart disease surgery. (åbner nyt vindue)

Changlani DK, Devendaran V, Murmu UC, Ganesan S, Varghese R, Kumar RS.

Kilde‎: Asian Cardiovasc Thorac Ann 2012;20(2):120-5.

Indekseret‎: PubMed 22499956

DOI‎: 10.1177/0218492311433614

https://www.ncbi.nlm.nih.gov/pubmed/22499956 (åbner nyt vindue)

Use of recombinant factor VIIa for uncontrolled bleeding in neonates after cardiopulmonary bypass. (åbner nyt vindue)

Guzzetta NA, Huch S, Fernandez JD, Tosone SR, Miller BE.

Kilde‎: Paediatr Anaesth 2009;19(4):364-70.

Indekseret‎: PubMed 19143947

DOI‎: 10.1111/j.1460-9592.2008.02905.x

https://www.ncbi.nlm.nih.gov/pubmed/19143947 (åbner nyt vindue)

Review of the off-label use of recombinant activated factor VII in pediatric cardiac surgery patients. (åbner nyt vindue)

Guzzetta NA, Russell IA, Williams GD.

Kilde‎: Anesth Analg 2012;115(2):364-78.

Indekseret‎: PubMed 22652310

DOI‎: 10.1213/ANE.0b013e31825aff10

https://www.ncbi.nlm.nih.gov/pubmed/22652310 (åbner nyt vindue)

Is recombinant activated factor VII effective in the treatment of excessive bleeding after paediatric cardiac surgery? (åbner nyt vindue)

Okonta KE, Edwin F, Falase B.

Kilde‎: Interact Cardiovasc Thorac Surg 2012;15(4):690-4.

Indekseret‎: PubMed 22811512

DOI‎: 10.1093/icvts/ivs309

https://www.ncbi.nlm.nih.gov/pubmed/22811512 (åbner nyt vindue)

Cardiac surgery without blood products in a Jehovah's Witness child with factor VII deficiency. (åbner nyt vindue)

Pérez-Ferrer A, Gredilla E, de Vicente J, Laporta Y.

Kilde‎: J Cardiothorac Vasc Anesth 2012;26(4):651-3.

Indekseret‎: PubMed 21924639

DOI‎: 10.1053/j.jvca.2011.07.012

https://www.ncbi.nlm.nih.gov/pubmed/21924639 (åbner nyt vindue)

Use of recombinant activated factor VII for controlling refractory postoperative bleeding in children undergoing cardiac surgery with cardiopulmonary bypass. (åbner nyt vindue)

Pychyńska-Pokorska M, Pągowska-Klimek I, Krajewski W, Moll JJ.

Kilde‎: J Cardiothorac Vasc Anesth 2011;25(6):987-94.

Indekseret‎: PubMed 21835642

DOI‎: 10.1053/j.jvca.2011.05.012

https://www.ncbi.nlm.nih.gov/pubmed/21835642 (åbner nyt vindue)

Increased recombinant activated factor VII use and need for surgical reexploration following a switch from aprotinin to epsilon-aminocaproic acid in infant cardiac surgery. (åbner nyt vindue)

Scott JP, Costigan DJ, Hoffman GM, Simpson PM, Dasgupta M, Punzalan R, Berens RJ, Tweddell JS, Stuth EA.

Kilde‎: J Clin Anesth 2014;26(3):204-11.

Indekseret‎: PubMed 24809789

DOI‎: 10.1016/j.jclinane.2013.10.015

https://www.ncbi.nlm.nih.gov/pubmed/24809789 (åbner nyt vindue)

Recombinant activated factor VII for hemorrhage after pediatric cardiac surgery. (åbner nyt vindue)

Singh SP, Chauhan S, Choudhary M, Vasdev S, Talwar S.

Kilde‎: Asian Cardiovasc Thorac Ann 2012;20(1):19-23.

Indekseret‎: PubMed 22371937

DOI‎: 10.1177/0218492311432584

https://www.ncbi.nlm.nih.gov/pubmed/22371937 (åbner nyt vindue)

Recombinant factor VIIa to treat bleeding after cardiac surgery in an infant. (åbner nyt vindue)

Tobias JD, Berkenbosch JW, Russo P.

Kilde‎: Pediatr Crit Care Med 2003;4(1):49-51.

Indekseret‎: PubMed 12656542

DOI‎: 10.1097/01.PCC.0000031472.55687.4E

https://www.ncbi.nlm.nih.gov/pubmed/12656542 (åbner nyt vindue)

Recombinant factor VIIa to control excessive bleeding following surgery for congenital heart disease in pediatric patients. (åbner nyt vindue)

Tobias JD, Simsic JM, Weinstein S, Schechter W, Kartha V, Michler R.

Kilde‎: J Intensive Care Med 2004;19(5):270-3.

Indekseret‎: PubMed 15358945

DOI‎: 10.1177/0885066604267783

https://www.ncbi.nlm.nih.gov/pubmed/15358945 (åbner nyt vindue)

Recombinant activated factor VII in cardiac surgery: a systematic review. (åbner nyt vindue)

Warren O, Mandal K, Hadjianastassiou V, Knowlton L, Panesar S, John K, Darzi A, Athanasiou T.

Kilde‎: Ann Thorac Surg 2007;83(2):707-14.

Indekseret‎: PubMed 17258029

DOI‎: 10.1016/j.athoracsur.2006.10.033

https://www.ncbi.nlm.nih.gov/pubmed/17258029 (åbner nyt vindue)

Defining the role of recombinant activated factor VII in pediatric cardiac surgery: where should we go from here? (åbner nyt vindue)

Warren OJ, Rogers PL, Watret AL, de Wit KL, Darzi AW, Gill R, Athanasiou T.

Kilde‎: Pediatr Crit Care Med 2009;10(5):572-82.

Indekseret‎: PubMed 19451849

DOI‎: 10.1097/PCC.0b013e3181a642d5

https://www.ncbi.nlm.nih.gov/pubmed/19451849 (åbner nyt vindue)

Decreasing the need for transfusion: infant cardiac surgery using hemodilution and recombinant factor VIIa. (åbner nyt vindue)

Winch PD, Naguib AN, Bradshaw JR, Galantowicz M, Tobias JD.

Kilde‎: Pediatr Cardiol 2013;34(1):119-24.

Indekseret‎: PubMed 22760694

DOI‎: 10.1007/s00246-012-0398-1

https://www.ncbi.nlm.nih.gov/pubmed/22760694 (åbner nyt vindue)

Single-center experience: use of recombinant factor VIIa for acute life-threatening bleeding in children without congenital hemorrhagic disorder. (åbner nyt vindue)

Yilmaz D, Karapinar B, Balkan C, Akisü M, Kavakli K.

Kilde‎: Pediatr Hematol Oncol 2008;25(4):301-11.

Indekseret‎: PubMed 18484474

DOI‎: 10.1080/08880010802016904

https://www.ncbi.nlm.nih.gov/pubmed/18484474 (åbner nyt vindue)

Koagulationsfaktor-koncentrater

Perioperative monitoring of thromboelastograph on blood protection and recovery for severely cyanotic patients undergoing complex cardiac surgery. (åbner nyt vindue)

Cui Y, Hei F, Long C, Feng Z, Zhao J, Yan F, Wang Y, Liu J.

Kilde‎: Artif Organs 2010;34(11):955-60.

Indekseret‎: PubMed 21092037

DOI‎: 10.1111/j.1525-1594.2010.01148.x

https://www.ncbi.nlm.nih.gov/pubmed/21092037 (åbner nyt vindue)

Plasma fibrinogen concentration is correlated with postoperative blood loss in children undergoing cardiac surgery. A retrospective review. (åbner nyt vindue)

Faraoni D, Willems A, Savan V, Demanet H, De Ville A, Van der Linden P.

Kilde‎: Eur J Anaesthesiol 2014;31(6):317-26.

Indekseret‎: PubMed 24503704

DOI‎: 10.1097/EJA.0000000000000043

https://www.ncbi.nlm.nih.gov/pubmed/24503704 (åbner nyt vindue)

Efficacy and safety of fibrinogen concentrate in surgical patients: a meta-analysis of randomized controlled trials. (åbner nyt vindue)

Fominskiy E, Nepomniashchikh VA, Lomivorotov VV, Monaco F, Vitiello C, Zangrillo A, Landoni G.

Kilde‎: J Cardiothorac Vasc Anesth 2016;30(5):1196-204.

Indekseret‎: PubMed 27493092

DOI‎: 10.1053/j.jvca.2016.04.015

https://www.ncbi.nlm.nih.gov/pubmed/27493092 (åbner nyt vindue)

Hemostatic effects of fibrinogen concentrate compared with cryoprecipitate in children after cardiac surgery: a randomized pilot trial. (åbner nyt vindue)

Galas FR, de Almeida JP, Fukushima JT, Vincent JL, Osawa EA, Zeferino S, Câmara L, Guimarães VA, Jatene MB, Hajjar LA.

Kilde‎: J Thorac Cardiovasc Surg 2014;148(4):1647-55.

Indekseret‎: PubMed 24951020

DOI‎: 10.1016/j.jtcvs.2014.04.029

https://www.ncbi.nlm.nih.gov/pubmed/24951020 (åbner nyt vindue)

Four-factor prothrombin complex concentrates in paediatric patients—a retrospective case series. (åbner nyt vindue)

Noga T, Bruce AA, Blain H, Nahirniak S.

Kilde‎: Vox Sang 2016;110(3):253-7.

Indekseret‎: PubMed 26509839

DOI‎: 10.1111/vox.12353

https://www.ncbi.nlm.nih.gov/pubmed/26509839 (åbner nyt vindue)

Topiske hæmostatika

A comprehensive review of topical hemostatic agents: efficacy and recommendations for use. (åbner nyt vindue)

Achneck HE, Sileshi B, Jamiolkowski RM, Albala DM, Shapiro ML, Lawson JH.

Kilde‎: Ann Surg 2010;251(2):217-28.

Indekseret‎: PubMed 20010084

DOI‎: 10.1097/SLA.0b013e3181c3bcca

https://www.ncbi.nlm.nih.gov/pubmed/20010084 (åbner nyt vindue)

Resternotomy in pediatric cardiac surgery: CoSeal initial experience. (åbner nyt vindue)

Pace Napoleone C, Oppido G, Angeli E, Gargiulo G.

Kilde‎: Interact Cardiovasc Thorac Surg 2007;6(1):21-3.

Indekseret‎: PubMed 17669759

DOI‎: 10.1510/icvts.2006.141531

https://www.ncbi.nlm.nih.gov/pubmed/17669759 (åbner nyt vindue)

Viskoelastiske test til identificering af kirurgisk blødning og koagulationsdefekt

Utility of Sonoclot analysis and tranexamic acid in tetralogy of Fallot patients undergoing intracardiac repair. (åbner nyt vindue)

Aggarwal V, Kapoor PM, Choudhury M, Kiran U, Chowdhury U.

Kilde‎: Ann Card Anaesth 2012;15(1):26-31.

Indekseret‎: PubMed 22234018

DOI‎: 10.4103/0971-9784.91477

https://www.ncbi.nlm.nih.gov/pubmed/22234018 (åbner nyt vindue)

Perioperative monitoring of thromboelastograph on blood protection and recovery for severely cyanotic patients undergoing complex cardiac surgery. (åbner nyt vindue)

Cui Y, Hei F, Long C, Feng Z, Zhao J, Yan F, Wang Y, Liu J.

Kilde‎: Artif Organs 2010;34(11):955-60.

Indekseret‎: PubMed 21092037

DOI‎: 10.1111/j.1525-1594.2010.01148.x

https://www.ncbi.nlm.nih.gov/pubmed/21092037 (åbner nyt vindue)

Thromboelastometry-guided intraoperative haemostatic management reduces bleeding and red cell transfusion after paediatric cardiac surgery. (åbner nyt vindue)

Nakayama Y, Nakajima Y, Tanaka KA, Sessler DI, Maeda S, Iida J, Ogawa S, Mizobe T.

Kilde‎: Br J Anaesth 2015;114(1):91-102.

Indekseret‎: PubMed 25303988

DOI‎: 10.1093/bja/aeu339

https://www.ncbi.nlm.nih.gov/pubmed/25303988 (åbner nyt vindue)

KARDIOTORAKAL- OG KARKIRURGI (PÆDIATRI)
Optimere hæmostase
Dansk
Optimere hæmostase
https://assetsnffrgf-a.akamaihd.net/assets/ct/1add6d1d93/images/syn_placeholder_sqr.png

Kontaktudvalg til Hospitaler (KUH)

Ret henvendelse til lokale kontaktpersoner der uden betaling hjælper læger som behandler patienter der er Jehovas Vidner.

Kontakt

Informationsmateriale til sundhedspersonale

Indbefatter følgende emner: Kliniske strategier for behandling af hæmoragi og anæmi uden blodtransfusion, Jehovas Vidners religiøse og etiske holdning til lægebehandling og den hjælp Vidnerne tilbyder læger gennem deres globale netværk Kontaktudvalg til Hospitaler.

Se materiale der kan downloades

Videoer

Behandlingsmuligheder læger kan gøre brug af når de skal behandle Jehovas Vidner, såvel som lægefaglige og etiske overvejelser.

Se videoer